These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7236870)

  • 21. Long-acting propranolol (Inderal LA): pharmacokinetics, pharmacodynamics and therapeutic use.
    Mishriki AA; Weidler DJ
    Pharmacotherapy; 1983; 3(6):334-41. PubMed ID: 6361703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hollow fibers as an oral sustained-release delivery system using propranolol hydrochloride.
    Hussain MA; DiLuccio RC; Shefter E; Hurwitz AR
    Pharm Res; 1989 Dec; 6(12):1052-5. PubMed ID: 2622860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioavailability of atenolol formulations.
    Mcainsh J; Simpson WT; Holmes BF; Young J; Ellis SH
    Biopharm Drug Dispos; 1980; 1(6):323-32. PubMed ID: 7459427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of verapamil and norverapamil in patients with hypertension: a comparison of oral conventional and sustained release formulations.
    Jørgensen NP; Walstad RA
    Pharmacol Toxicol; 1988 Aug; 63(2):105-7. PubMed ID: 3186615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and pharmacodynamics of long-acting propranolol 60-mg capsules: a comparative evaluation.
    Marino MR; Dey M; Garg DC; Jallad NS; Dorick DM; Martinez JJ; Weidler DJ
    J Clin Pharmacol; 1987 Nov; 27(11):885-91. PubMed ID: 3429696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug input rate from the GI-tract. Michaelis-Menten kinetics and the bioavailability of slow release verapamil and nifedipine.
    Woodcock BG; Menke G; Fischer A; Köhne H; Rietbrock N
    Drug Des Deliv; 1988 May; 2(4):299-310. PubMed ID: 3255321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biopharmaceutical characteristics of a new propranolol/hydrochlorothiazide tablet combination.
    Kraml M; Dubuc J; Dvornik D; Patterson-Kreuscher S; Perdue H; Lee TY; Mullane J
    Biopharm Drug Dispos; 1982; 3(1):55-65. PubMed ID: 7082779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride.
    Feng XM; Ren Q; Zhang WZ; Shen HF; Rong ZX; Fang C; Chen HZ
    J Pharm Pharmacol; 2008 Jul; 60(7):817-22. PubMed ID: 18549667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of propranolol after single and multiple dosing with sustained release propranolol or propranolol CR (innopran XL) , a new chronotherapeutic formulation.
    Sica D; Frishman WH; Manowitz N
    Heart Dis; 2003; 5(3):176-81. PubMed ID: 12783630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-dosing plasma concentrations and beta-adrenoceptor blocking effects during repeated once daily dosing with 160 mg sustained-release propranolol (Inderal LA) and 16/260 oxprenolol Oros to healthy volunteers.
    Moppert J; Degen PH; Racine-Poon A
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):197S-201S. PubMed ID: 2988591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propranolol: pooled Michaelis-Menten parameters and the effect of input rate on bioavailability.
    Wagner JG
    Clin Pharmacol Ther; 1985 May; 37(5):481-7. PubMed ID: 3987171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suprofen sustained release kinetics in healthy male volunteers. 1st communication: a single dose open crossover bioavailability study of suprofen sustained release tablets versus capsules.
    Michos N; Zulliger HW; Barkworth MF; Johnson KJ; Rehm KD; Töberich H; Klein G
    Arzneimittelforschung; 1986 Jun; 36(6):941-8. PubMed ID: 3741528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-vivo evaluation in man of a hydrophilic matrix containing propylthiouracil.
    Kabanda L; Lefebvre RA; Remon JP
    J Pharm Pharmacol; 1996 Oct; 48(10):1023-6. PubMed ID: 8953503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study.
    Horai Y; Ishizaki T; Sasaki T; Chiba K; Suganuma T; Echizen H; Ohnishi A
    Eur J Clin Pharmacol; 1983; 24(1):79-87. PubMed ID: 6832206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacokinetics of buffered propranolol sublingual tablet (Promptol™)-application of a new "physiologically based" model to assess absorption and disposition.
    Wang Y; Wang Z; Zuo Z; Tomlinson B; Lee BT; Bolger MB; Chow MS
    AAPS J; 2013 Jul; 15(3):787-96. PubMed ID: 23605805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scale-up effects on dissolution and bioavailability of propranolol hydrochloride and metoprolol tartrate tablet formulations.
    Eddington ND; Rekhi GS; Lesko LJ; Augsburger LL
    AAPS PharmSciTech; 2000 Jun; 1(2):E14. PubMed ID: 14727847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and bioavailability of a controlled release amoxicillin formulation.
    Arancibia A; González G; Icarte A; Arancibia M; Arancibia P
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):97-100. PubMed ID: 3557736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thermal sintering: a novel technique used in the design, optimization and biopharmaceutical evaluation of propranolol HCl gastric floating tablets.
    Venkata Srikanth M; Songa AS; Nali SR; Battu JR; Kolapalli VR
    Drug Dev Ind Pharm; 2014 Jan; 40(1):33-45. PubMed ID: 23317339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative bioavailability study of a conventional and two controlled release oral formulations of Tegretol (carbamazepine)--200 mg.
    Revankar SN; Bhatt AD; Desai ND; Bolar HV; Sane SP; Tipnis HP
    J Assoc Physicians India; 1999 Sep; 47(9):886-9. PubMed ID: 10778658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.